Finance

Beta
Lists
2591:HKG
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HK$9.33
-6.70%
(-0.67) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2591...
Open
HK$9.99
High
HK$10.38
Low
HK$9.32
Mkt. cap
4.26B
Avg. vol.
5.67M
Volume
4.20M
52-wk high
HK$74.00
52-wk low
HK$9.32
EPS
-HK$0.86
Shares outstanding
420.29M
No. of employees
193
Open
HK$9.99
High
HK$10.38
Low
HK$9.32
Mkt. cap
4.26B
Avg. vol.
5.67M
Volume
4.20M
52-wk high
HK$74.00
52-wk low
HK$9.32
EPS
-HK$0.86
Shares outstanding
420.29M
No. of employees
193
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2591 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2591 in the last 3 months.
Highest
Current HK$9.33
HK$28.10 (+201.18%)
Average
HK$28.10 (+201.18%)
Lowest
HK$28.10 (+201.18%)
News stories
From sources across the web
About Guangzhou Innogen Pharmaceutl Grp Co Ltd
CEO-
Employees193
Founded2014
Headquarters-
SectorBiotechnology
Websiteinnogenpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
28.22M
28.22M
37.53M
37.53M
Cost of goods sold
2.98M
2.98M
4.25M
4.25M
Cost of revenue
2.98M
2.98M
4.25M
4.25M
Research and development expenses
49.54M
49.54M
53.35M
53.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.80M
37.80M
89.23M
89.23M
Operating expense
88.89M
88.89M
143.08M
143.08M
Total operating expenses
91.87M
91.87M
147.32M
147.32M
Operating income
-63.64M
-63.64M
-109.79M
-109.79M
Other non operating income
70.50K
70.50K
19.50K
19.50K
EBT including unusual items
-61.24M
-61.24M
-109.45M
-109.45M
EBT excluding unusual items
-62.84M
-62.84M
-107.84M
-107.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
1.55M
1.55M
501.50K
501.50K
Net income
-61.24M
-61.24M
-109.45M
-109.45M
Net profit margin
-216.97%
-216.97%
-291.61%
-291.61%
Earnings per share
-
-
-
-
Interest and investment income
946.00K
946.00K
5.80M
5.80M
Interest expense
-212.50K
-212.50K
-646.00K
-646.00K
Net interest expenses
733.50K
733.50K
5.16M
5.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
-61.86M
-61.86M
-107.99M
-107.99M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer